Papers associated with heart (and arfgap1)

Limit to papers also referencing gene:
Show all heart papers

Results 1 - 34 of 34 results

Page(s): 1

Sort Newest To Oldest

Sort Oldest To Newest

	Bioelectric signaling: Reprogrammable circuits underlying embryogenesis, regeneration, and cancer., Levin M., Cell. April 15, 2021;
	Molecular Mechanism of Autosomal Recessive Long QT-Syndrome 1 without Deafness., Oertli A., Int J Mol Sci. January 23, 2021; 22 (3):
	Eag Domains Regulate LQT Mutant hERG Channels in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes., Liu QN., PLoS One. April 22, 2015; 10 (4): e0123951.
	Functional assembly of Kv7.1/Kv7.5 channels with emerging properties on vascular muscle physiology., Oliveras A., Arterioscler Thromb Vasc Biol. July 1, 2014; 34 (7): 1522-30.
	Domain-domain interactions determine the gating, permeation, pharmacology, and subunit modulation of the IKs ion channel., Zaydman MA., Elife. March 12, 2014; 3 e03606.
	AMP-activated protein kinase downregulates Kv7.1 cell surface expression., Andersen MN., Traffic. January 1, 2012; 13 (1): 143-56.
	Identification and functional characterization of KCNQ1 mutations around the exon 7-intron 7 junction affecting the splicing process., Tsuji-Wakisaka K., Biochim Biophys Acta. November 1, 2011; 1812 (11): 1452-9.
	Extracellular potassium inhibits Kv7.1 potassium channels by stabilizing an inactivated state., Larsen AP., Biophys J. August 17, 2011; 101 (4): 818-27.
	PKC activation and PIP(2) depletion underlie biphasic regulation of IKs by Gq-coupled receptors., Matavel A., J Mol Cell Cardiol. May 1, 2009; 46 (5): 704-12.
	Ancillary subunits and stimulation frequency determine the potency of chromanol 293B block of the KCNQ1 potassium channel., Bett GC., J Physiol. November 1, 2006; 576 (Pt 3): 755-67.
	Identification and characterisation of a novel KCNQ1 mutation in a family with Romano-Ward syndrome., Zehelein J., Biochim Biophys Acta. November 5, 2004; 1690 (3): 185-92.
	Acute effects of dronedarone on both components of the cardiac delayed rectifier K+ current, HERG and KvLQT1/minK potassium channels., Thomas D., Br J Pharmacol. November 1, 2003; 140 (5): 996-1002.
	Human beta(3)-adrenoreceptors couple to KvLQT1/MinK potassium channels in Xenopus oocytes via protein kinase C phosphorylation of the KvLQT1 protein., Kathöfer S., Naunyn Schmiedebergs Arch Pharmacol. August 1, 2003; 368 (2): 119-26.
	Interaction with GM130 during HERG ion channel trafficking. Disruption by type 2 congenital long QT syndrome mutations. Human Ether-à-go-go-Related Gene., Roti EC., J Biol Chem. December 6, 2002; 277 (49): 47779-85.
	Inhibitory effects of volatile anesthetics on currents produced on heterologous expression of KvLQT1 and minK in Xenopus oocytes., Chen X., Vascul Pharmacol. July 1, 2002; 39 (1-2): 33-8.
	Chromanol 293B, a blocker of the slow delayed rectifier K+ current (IKs), inhibits the CFTR Cl- current., Bachmann A., Naunyn Schmiedebergs Arch Pharmacol. June 1, 2001; 363 (6): 590-6.
	Short- and long-term effects of amiodarone on the two components of cardiac delayed rectifier K(+) current., Kamiya K., Circulation. March 6, 2001; 103 (9): 1317-24.
	Cloning and function of the rat colonic epithelial K+ channel KVLQT1., Kunzelmann K., J Membr Biol. January 15, 2001; 179 (2): 155-64.
	Expression and function of colonic epithelial KvLQT1 K+ channels., Kunzelmann K., Clin Exp Pharmacol Physiol. January 1, 2001; 28 (1-2): 79-83.
	Functional coupling of human beta 3-adrenoreceptors to the KvLQT1/MinK potassium channel., Kathöfer S., J Biol Chem. September 1, 2000; 275 (35): 26743-7.
	Molecular basis for differential sensitivity of KCNQ and I(Ks) channels to the cognitive enhancer XE991., Wang HS., Mol Pharmacol. June 1, 2000; 57 (6): 1218-23.
	KChAP as a chaperone for specific K(+) channels., Kuryshev YA., Am J Physiol Cell Physiol. May 1, 2000; 278 (5): C931-41.
	Independent and exclusive modulation of cardiac delayed rectifying K+ current by protein kinase C and protein kinase A., Lo CF., Circ Res. November 16, 1998; 83 (10): 995-1002.
	Activation and inactivation of homomeric KvLQT1 potassium channels., Pusch M., Biophys J. August 1, 1998; 75 (2): 785-92.
	A novel benzodiazepine that activates cardiac slow delayed rectifier K+ currents., Salata JJ., Mol Pharmacol. July 1, 1998; 54 (1): 220-30.
	Gating of I(sK) channels expressed in Xenopus oocytes., Tzounopoulos T., Biophys J. May 1, 1998; 74 (5): 2299-305.
	Suppression of slow delayed rectifier current by a truncated isoform of KvLQT1 cloned from normal human heart., Jiang M., J Biol Chem. September 26, 1997; 272 (39): 24109-12.
	The role of the IsK protein in the specific pharmacological properties of the IKs channel complex., Busch AE., Br J Pharmacol. September 1, 1997; 122 (2): 187-9.
	Block by propofol and thiopentone of the min K current (IsK) expressed in Xenopus oocytes., Heath BM., Naunyn Schmiedebergs Arch Pharmacol. September 1, 1997; 356 (3): 404-9.
	A minK-HERG complex regulates the cardiac potassium current I(Kr)., McDonald TV., Nature. July 17, 1997; 388 (6639): 289-92.
	Properties and regulation of the minK potassium channel protein., Kaczmarek LK., Physiol Rev. July 1, 1997; 77 (3): 627-41.
	KvLQT1, a voltage-gated potassium channel responsible for human cardiac arrhythmias., Yang WP., Proc Natl Acad Sci U S A. April 15, 1997; 94 (8): 4017-21.
	Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel., Sanguinetti MC., Nature. November 7, 1996; 384 (6604): 80-3.
	A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel., Sanguinetti MC., Cell. April 21, 1995; 81 (2): 299-307.

Page(s): 1